首页> 外文期刊>Journal of endourology >Single center comparison of laparoscopic cryoablation and CT-guided percutaneous cryoablation for renal tumors.
【24h】

Single center comparison of laparoscopic cryoablation and CT-guided percutaneous cryoablation for renal tumors.

机译:腹腔镜冷冻消融和CT引导的经皮冷冻消融对肾肿瘤的单中心比较。

获取原文
获取原文并翻译 | 示例
       

摘要

BACKGROUND AND PURPOSE: Cryoablation has demonstrated therapeutic effectiveness for selected renal tumors. We compared our perioperative and short-term outcomes of laparoscopic (LAP) v percutaneous (PERC) renal cryoablation. PATIENTS AND METHODS: Thirty-four patients (18 men/16 women) underwent a LAP and 26 patients (19 men/7 women) underwent a PERC procedure between September1998 and January 2007. LAP cryoablation was performed transperitoneally with ultrasonographic monitoring. PERC cryoablation was performed with CT guidance. Follow-up imaging was obtained at regular intervals. RESULTS: Mean follow-up was 25 months. Average age (years) was 67.0 for the LAP and 69.7 for the PERC procedure (P = 0.307). Mean body mass index (kg/m(2)) was 29.8 for those undergoing LAP and 28.7 for those undergoing PERC procedures (P = 0.543). Mean tumor size (cm) was 2.9 for LAP patients and 3.1 for PERC patients (P = 0.432). Anterior tumors comprised 61.7% of LAP and 15.4% of PERC procedures (P < 0.001). Posterior tumors comprised 32.4% of LAP and 65.4% of PERC procedures (P = 0.01). Mean procedure time (minutes) was 165.7 for LAP and 106.6 for PERC procedures (P < 0.001). Hospital stay (days) was 2.6 for those undergoing LAP and 1.8 for those undergoing PERC procedures (P < 0.001). Both LAP patients (82.4%) and PERC patients (19.2%) needed postoperative narcotics (P < 0.001). Atelectasis developed in 70.6% of LAP patients and 34.6% of PERC patients (P = 0.005). Residual enhancement was seen in 11.5% of PERC patients and 2.9% of LAP patients (P = 0.192). Complications developed in 14.7% of LAP patients and 26.9% of PERC patients (P = 0.248). 1-year, 2-year, and 3-year disease-specific survival for the two groups was 100%. Tumor size > 4 cm and endophytic location were significantly associated with residual enhancement. CONCLUSIONS: LAP and PERC renal cryoablation have similar short-term outcomes. Significantly more anterior tumors were approached laparoscopically and significantly more posterior tumors were approached percutaneously. The PERC approach may offer advantages regarding hospital stay, narcotic need, and development of atelectasis. Longer-term data are needed to establish success of this approach.
机译:背景与目的:冷冻消融术已显示出对某些肾肿瘤的治疗效果。我们比较了腹腔镜(LAP)VS经皮(PERC)肾冷冻消融术的围手术期和短期结局。患者与方法:1998年9月至2007年1月,对34例患者(18例男性/ 16例女性)进行了LAP手术,对26例患者(19例男性/ 7例女性)进行了PERC手术。对LAP冷冻消融的方法是经腹膜超声检查。在CT引导下进行PERC冷冻消融。定期获得随访影像。结果:平均随访时间为25个月。 LAP的平均年龄(岁)为67.0,PERC程序的平均年龄为69.7(P = 0.307)。接受LAP者的平均体重指数(kg / m(2))为29.8,接受PERC程序者为28.7(P = 0.543)。 LAP患者的平均肿瘤大小(cm)为2.9,PERC患者为3.1(P = 0.432)。前部肿瘤占LAP的61.7%和PERC手术的15.4%(P <0.001)。后部肿瘤占LAP的32.4%,占PERC手术的65.4%(P = 0.01)。 LAP的平均手术时间(分钟)为165.7,PERC手术的平均手术时间(分钟)为106.6(P <0.001)。接受LAP的患者住院天数为2.6,接受PERC手术的患者住院天数为1.8(P <0.001)。 LAP患者(82.4%)和PERC患者(19.2%)均需要术后麻醉剂(P <0.001)。肺不张发生在70.6%的LAP患者和34.6%的PERC患者中(P = 0.005)。在PERC患者中11.5%和LAP患者中2.9%观察到残留增强(P = 0.192)。 LAP患者的并发症发生率为14.7%,PERC患者的并发症发生率为26.9%(P = 0.248)。两组的1年,2年和3年疾病特异性存活率为100%。肿瘤大小> 4 cm和内生位置与残余增强显着相关。结论:LAP和PERC肾冷冻消融术具有相似的短期结果。腹腔镜治疗的前部肿瘤明显更多,经皮治疗的后部肿瘤明显更多。 PERC方法可能在住院,麻醉需要和肺不张发展方面具有优势。需要长期数据来确定这种方法的成功。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号